Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Tampilan
• 06/15/23
0
0
Menanamkan
administrator
Pelanggan
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru